0001209191-20-046161.txt : 20200811 0001209191-20-046161.hdr.sgml : 20200811 20200811170247 ACCESSION NUMBER: 0001209191-20-046161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200807 FILED AS OF DATE: 20200811 DATE AS OF CHANGE: 20200811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRASSO MARC CENTRAL INDEX KEY: 0001748894 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 201093188 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 3033 SCIENCE PARK ROAD, SUITE 220 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-07 0 0001422143 Kura Oncology, Inc. KURA 0001748894 GRASSO MARC C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 CFO, CBO Common Stock 2020-08-07 4 M 0 7102 15.47 A 10000 D Common Stock 2020-08-07 4 S 0 10000 20.00 D 0 D Option to purchase common stock 15.47 2020-08-07 4 M 0 7102 0.00 D 2029-01-21 Common Stock 7102 132898 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Includes 2,898 shares acquired on May 20, 2019 pursuant to the Issuer's Employee Stock Purchase Plan. This option vests in 48 equal monthly installments commencing on January 22, 2019. James Basta, Attorney-in-fact for Marc Grasso 2020-08-11